Investors

Growing Shareholder Value

Press Releases

Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification

Oct 10, 2019
Read More

Abiomed Announces 1,000th Patient Treated with Impella in Japan

Oct 07, 2019
Read More

Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock; Escalation Protocols Initiated

Sep 27, 2019
Read More

PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes

Sep 26, 2019
Read More

Abiomed Receives FDA PMA Approval for Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump

Sep 25, 2019
Read More

Highest Court in Germany Affirms Strength of Abiomed’s Patents

Sep 23, 2019
Read More

Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019

Sep 17, 2019
Read More

Abiomed to Present at the Morgan Stanley Global Healthcare Conference

Sep 03, 2019
Read More

Impella® SmartAssist Platform Launches at ESC, Designed to Further Improve Patient Outcomes

Aug 31, 2019
Read More

Abiomed Announces Q1 FY 2020 Revenue of $208 Million and 29.2% Operating Margin

Aug 01, 2019
Read More
View all